perizam 2mg/ml oral suspension
rosemont pharmaceuticals ltd - clobazam - oral suspension - 2mg/1ml
clobazam 5mg/5ml oral suspension sugar free
thame laboratories ltd - clobazam - oral suspension - 1mg/1ml
clobazam 10mg/5ml oral suspension sugar free
thame laboratories ltd - clobazam - oral suspension - 2mg/1ml
zacco 5mg/5ml oral suspension
thame laboratories ltd - clobazam - oral suspension - 1mg/1ml
zacco 10mg/5ml oral suspension
thame laboratories ltd - clobazam - oral suspension - 2mg/1ml
clobazam oral suspension 5mg/5ml
atnahs pharma uk limited - clobazam - oral suspension - clobazam 5 mg/5ml - psycholeptics
clobazam oral suspension 10mg/5ml
atnahs pharma uk limited - clobazam - oral suspension - clobazam 10 mg/5ml - psycholeptics
clobazam micro labs 10 mg tabletten
micro labs gmbh (8144276) - clobazam - tablette - 10 mg - teil 1 - tablette; clobazam (12632) 10 milligramm
clobazam micro labs 20 mg tabletten
micro labs gmbh (8144276) - clobazam - tablette - 20 mg - teil 1 - tablette; clobazam (12632) 20 milligramm
perizam 1mg/ml oral suspension
rosemont pharmaceuticals ltd - clobazam - oral suspension - 1 milligram(s)/millilitre - benzodiazepine derivatives; clobazam - anxiolytics - it is indicated in adults for the short-term symptomatic treatment (2-4 weeks) only of anxiety that is severe, disabling or subjecting the individual to unacceptable distress. in treatment of anxiety states associated with affected disorders, perizam must only be used in conjunction with adequate treatments for the underlying disorder. in patients with schizophrenic or other psychotic illnesses, use of benzodiazepines is recommended only for short term symptomatic management of hyperarousal and agitation. benzodiazepines do not possess antipsychotic properties. perizam may be used as adjunctive therapy in epilepsy in adults or children over 6, if standard treatment with one or more anticonvulsants has failed.